###### Summary

What is already known about this subject?
=========================================

-   Dyspepsia is common globally, yet there is a lack of evidence from the African, sub-Saharan African and specifically Rwandan setting including the prevalence, and factors associated with its presence and severity.

What are the new findings?
==========================

-   The national dyspepsia prevalence was 14.2% (283/2000). Thus, study validates multiple risk factors such as gender, aspirin, alcohol non-steroidal anti-inflammatory medication use, and profession/socioeconomic status as associated with dyspepsia prevalence. Dyspeptics had a significantly lower gastrointestinal-related quality of life, though the sociodemographic factors measured did not modify the observed quality of life.

How might it impact on clinical practice in the foreseeable future?
===================================================================

-   This study validates the increasing importance that is being placed on global dyspepsia---but specifically the high burden of disease attributable to the Rwandan and sub-Saharan Africa. This corroborates gender, aspirin and alcohol as associated with the prevalence of dyspepsia. Further studies might further explore these associations as well as explore dose--response relations.

###### Strengths and limitations of this study

-   A large population data set with a stratified sampling technique.

-   Validated and internationally comparable questionnaires used in data collection, with a strict dyspepsia definition.

-   Native Rwandan and Kinyarwanda speakers used to approach the participants.

-   However, as a cross-sectional survey, we are unable to comment on causality, nor specifically whether the symptoms had attributable organic pathology or were from functional dyspepsia---and whether uninvestigated dyspepsia has a different natural history in this population to others.

-   We were also unable to assess changes in the participants' dyspepsia and quality of life scores over time.

Introduction {#s1}
============

Dyspepsia is a constellation of symptoms referable to the gastroduodenal territory of the upper gastrointestinal tract, specifically unpleasant sensations of epigastric pain, burning, postprandial fullness or early satiety, sometimes in association with heartburn.[@R1] Dyspepsia is an extremely common symptom, accounting for 3%--4% of worldwide primary healthcare visits,[@R3] and the resultant social, psychological, and healthcare-related[@R4] burden of worldwide disease[@R1] is both economically significant and associated with reduced quality of life among those afflicted.[@R5]

The burden of dyspepsia in the primary care setting in sub-Saharan Africa is significant, but poorly characterised,[@R6] as most patients do not seek medical investigation,[@R7] with most prior evidence arising from work done in Nigeria.[@R8] Two prior studies have sought to the burden of dyspepsia in Rwanda among hospital-based healthcare workers[@R6] and patients referred for endoscopy,[@R11] but such data cannot be easily extrapolated to predict overall disease burden among the general population.

There is thus a lamentable deficit in population-level data about the prevalence of dyspepsia in sub-Saharan Africa, and its sociodemographic determinants, which limits public health and health system interventions aimed at reducing the burden of disease in these settings. Therefore, we undertook to investigate the prevalence of dyspepsia and its effects on gastrointestinal-related quality of life (GI-QoL) in a representative sample of the Rwandan general population, using locally validated, internationally accepted tools.

Methods {#s2}
=======

We undertook a population-based clustered cross-sectional survey between November 2015 and January 2016, nationwide in Rwanda, with study subjects recruited from Kigali city and each of the four provinces.

Rwanda has a higher ordered local governance structure and this was leveraged to assist recruitment for the study. All residents in Rwanda are part of a 'village' which is in turn part of an administrative district, and these administrative districts in turn coalesce to give rise to four provinces, and a separate administrative area for the capital, Kigali, each with separate local governments. The vast majority of people identifying as Rwandan speak a single common language, Kinyarwanda, and all study consent and questionnaire processes were conducted in Kinyarwanda.

Sample size {#s2-1}
-----------

A sample size of 1876 was calculated as necessary to detect the population prevalence of dyspepsia to within a 3.2% margin of error at a two-sided 95% CI, with a design effect factor of 2 and using an estimated dyspepsia prevalence of 5%, an intentionally more statistically conservative figure than the 30% used in previous studies for sample size calculation.[@R6] This number was increased by 6.5% to cater for possible non-responders, giving a total target sample size of 2000 participants.

Sampling strategy {#s2-2}
-----------------

Villages were chosen from across Rwanda for inclusion as recruitment sites in the study according to two levels of stratification. First, a list was made of all administrative districts within each of the four provinces as well as Kigali city (to make five 'provinces' in total), and four separate administrative districts in each province were randomly selected. A list of villages (a smaller administrative unit covering the whole of the population in both rural and urban areas) containing more than 100 households within each chosen administrative district was then compiled, and four villages were chosen at random from this list. In Kigali city there are only three districts, therefore two villages were selected from one district and one from each of the other two districts to make a total of four villages. Subsequently in each of these villages, consecutive households were visited in person by study research personnel and all willing eligible participants within each household recruited until 100 people had been recruited in total in that village. One hundred people were recruited in each village to make a total of 2000 participants from 20 villages, representing 19 different districts (four from each province and three from Kigali) across Rwanda.

Participant inclusion criteria:

-   Participants over 21 years of age.

-   Those able to give written informed consent (participants unable to read and write were enrolled if accompanied by a relative or friend who could assist them with the consent process).

Participant exclusion criteria:

-   People with known mental health or intellectual disorders where assessing informed consent would be problematic.

-   People who were not fluent in Kinyarwanda language and valid informed consent could therefore not be gained.

Questionnaire {#s2-3}
-------------

The study questionnaire compiled after piloting, included sociodemographic data, the Short Form Leeds Dyspepsia Questionnaire (SF-LDQ) and the Short Form Nepean Dyspepsia Index (SF-NDI), both of which have been translated and validated for use in this context in Kinyarwanda.^6\ 11^

Sociodemographic data {#s2-4}
---------------------

The collected information included gender, age, province of residence, occupation, and socioeconomic status. Socioeconomic status was grouped into four strata according to established Rwandan governmental categories: the lowest income who did not own their house and did not have food security (category 1), those with low incomes but who owned their house and had food security (category 2), those with their own house and a modest income (category 3), and the more affluent (category 4).

Short Form Leeds Dyspepsia Questionnaire {#s2-5}
----------------------------------------

The SF-LDQ is an eight-item symptom-based questionnaire based on the frequency and severity of dyspepsia symptoms, measured in the symptom domains of indigestion, heartburn, regurgitation and nausea. Scores are ascribed according to the frequency and severity of each symptom, with larger scores indicating more severe dyspepsia, a possible score range of 0--32, and a discriminatory cut-off score of 16 for severe dyspepsia.[@R12] The questionnaire has been internationally validated[@R12] as well as specifically in the Rwandan context.[@R6] Specifically, the cut-off score of ≥16 has been validated in this context to accurately detect dyspepsia that correlates with the clinical diagnosis of experienced clinicians.[@R11]

Short Form Nepean Dyspepsia Index {#s2-6}
---------------------------------

The SF-NDI was created based on the Nepean Dyspepsia Index, which was developed to study quality of life in functional dyspepsia.[@R13] It comprises a 10-item questionnaire with two questions on each of five quality of life indicators known to be affected by dyspepsia (tension/anxiety; interference with daily activities; disruption to regular eating/drinking; knowledge and control over disease symptoms; and interference with work/study). Each aspect is rated according to severity by a 5-point Likert scale, from 0 ('not at all' or 'not applicable') to 5 ('extremely'), and the total score from the subscale is aggregated and collated to generate a total score from 0 (the lowest health score) up to 100 (the highest score), with higher scores indicating a worse health-related quality of life. The questionnaire has again been validated internationally[@R15] as well as specifically in the Rwandan context.^6\ 11^

Data and statistical analysis {#s2-7}
-----------------------------

Data were manually captured on paper forms, and double entered into a database software package STATA (V.13) with manual cross-checking by a second researcher. Determination of the risk of dyspepsia via SF-LDQ score, and severity of dyspepsia using SF-NDI score (once the diagnosis of dyspepsia was made) was via univariate and multiple unconditional logistic regression, in order to analyse the relative contribution of each factor to the overall model.

Results {#s3}
=======

Demographics {#s3-1}
------------

Two thousand participants were recruited from November 2015 to January 2016, with equal numbers (n=400/2000 (20%)) taken from each of Kigali city and the four provinces.

There was a slight preponderance of females (1168/2000, 58%) among recruited participants. There was a roughly equal number of participants in each of the age demographics, 33.1% (661/2000) were 30 years of age or younger, 36.5% (730/2000) were 31--45 years of age while the remaining 30.4% (609/2000) were over the age of 45 years. A demographic breakdown is available in [table 1](#T1){ref-type="table"}.

###### 

Socioeconomic data with univariate dyspepsia risk factors (SF-LDQ)

  Variable               Proportion with dyspepsia (n/total (%))   OR      SE      P value   95% CI
  ---------------------- ----------------------------------------- ------- ------- --------- ----------------
  Age                                                                                        
   ≤30                   87/661 (13.2)                             1.003   0.005   0.58      0.989 to 1.018
   31--45                105/730 (14.4)                                                      
   ≥45                   91/609 (14.9)                                                       
  Gender                                                                                     
   Male                  79/832 (9.5)                              --      --      --        
   Female                204/1168 (17.5)                           2.017   0.16    0.001\*   1.618 to 2.514
  Profession                                                                                 
   Unemployed            20/135 (14.8)                             --      --      --        
   Farmer                209/1350 (15.5)                           0.979   0.309   0.95      0.408 to 2.351
   Student               17/123 (13.8)                             0.857   0.297   0.68      0.327 to 2.246
   Private sector        26/253 (10.3)                             0.612   0.17    0.152     0.283 to 1.323
   Public sector         5/109 (4.6)                               0.257   0.081   0.012\*   0.107 to 0.615
  Socioeconomic status                                                                       
   Category 1            44/221 (19.9)                             --      --      --        
   Category 2            165/1230 (13.4)                           0.623   0.103   0.045\*   0.395 to 0.985
   Category 3            72/541 (13.3)                             0.618   0.204   0.219     0.246 to 1.548
   Category 4            2/8 (25.0)                                1.341   0.524   0.495     0.453 to 3.968
  Marital status                                                                             
   Single                54/391 (13.8)                             --      --      --        
   Married               191/1387 (13.8)                           0.997   0.124   0.98      0.705 to 1.409
   Divorced              3/20 (15.0)                               1.101   0.404   0.805     0.398 to 3.047
   Widow                 35/202 (17.3)                             1.308   0.471   0.498     0.481 to 3.556
  Having children                                                                            
   Has children          224/1554 (14.4)                           --      --      --        
   No children           59/446 (13.2)                             0.905   0.074   0.292     0.721 to 1.137
  Smoking                                                                                    
   Never                 211/1600 (13.8)                           --      --      --        
   In the past           39/222 (17.6)                             1.403   0.282   0.167     0.803 to 2.451
   Currently             31/173 (17.9)                             1.437   0.236   0.091     0.912 to 2.265
  NSAID use                                                                                  
   Never                 104/738 (14.1)                            --      --      --        
   In the past           149/1164 (12.8)                           0.895   0.166   0.581     0.535 to 1.497
   Currently             27/81 (33.3)                              3.048   1.217   0.049\*   1.006 to 9.233
  Aspirin use                                                                                
   Never                 114/963 (10.6)                            --      --      --        
   In the past           136/681 (16.7)                            1.687   0.173   0.007\*   1.27 to 2.241
   Currently             25/59 (29.8)                              3.579   0.648   0.002\*   2.166 to 5.916
  Alcohol use                                                                                
   Never                 70/590 (11.9)                             --      --      --        
   In the past           84/415 (20.2)                             1.885   0.125   0.001\*   1.569 to 2.265
   Currently             128/990 (12.9)                            1.103   0.157   0.528     0.743 to 1.637

\*Denotes a significant value with p\<0.05.

NSAID, non-steroidal anti-inflammatory drug; SF-LDQ, Short Form Leeds Dyspepsia Questionnaire.

The prevalence of clinically significant dyspepsia in the general Rwandan population was 14.1% (283/2000), when defined by an SF-LDQ score greater than or equal to 16.

Univariate analysis of dyspepsia risk factors (SF-LDQ) {#s3-2}
------------------------------------------------------

Risk factors for dyspepsia that reached significance in a univariate model (see [table 1](#T1){ref-type="table"}) included: gender, profession, socioeconomic status, non-steroidal anti-inflammatory drug (NSAID), aspirin and alcohol use. Factors that did not reach significance included age, marital status, having children, and smoking. Where the stated profession was unsure/other or where the respondent was unsure of an exposure, as a subgroup this response was thought to be heterogeneous and not statistically analysed---hence subgroup totals may not always equal 2000.

Multivariate analysis of dyspepsia risk factors (SF-LDQ) {#s3-3}
--------------------------------------------------------

A multivariate model using an adjusted Wald test found that gender, current smoking, aspirin in the past and currently and alcohol use in the past remained significant for predicting dyspepsia while profession, socioeconomic status, and NSAID use did not (see [table 2](#T2){ref-type="table"}). The logistic regression was able to predict dyspepsia under the receiver operating characteristic curve being 0.6501 (95% CI 0.615 to 0.685).

###### 

Multivariate dyspepsia risk factors

  Variable       OR      SE      P value      95% CI
  -------------- ------- ------- ------------ ----------------
  Gender                                      
   Male          --      --      --           
   Female        2.209   0.165   \<0.0001\*   1.794 to 2.72
  Smoking                                     
   Never         --      --      --           
   In the past   1.349   0.322   0.279        0.695 to 2.619
   Currently     1.941   0.321   0.016\*      1.227 to 3.07
  Aspirin use                                 
   Never         --      --      --           
   In the past   1.608   0.191   0.016\*      1.157 to 2.234
   Currently     3.606   0.67    0.002\*      2.153 to 6.039
  Alcohol use                                 
   Never         --      --      --           
   In the past   1.751   0.172   0.005\*      1.333 to 2.3
   Currently     1.136   0.212   0.531        0.677 to 1.907

\*Denotes a significant value with p\<0.05.

Analysis of dyspepsia symptoms (by SF-LDQ) {#s3-4}
------------------------------------------

In our study, among those who suffered from dyspepsia, the most frequent severe symptom was upper abdominal pain and heartburn (both 42.4%), followed by nausea (33.6%) then regurgitation (27.2%). See [table 3](#T3){ref-type="table"} for more information.

###### 

SF-LDQ in dyspeptics and non-dyspeptics

  Total                  Symptom frequency (n, %)   Interference with lifestyle (n, %)                                     
  ---------------------- -------------------------- ------------------------------------ ----- ------- ------ ------- ---- -------
  Upper abdominal pain                                                                                                     
   Never                 1232                       71.8%                                8     2.8%    1347   78.5%   13   4.6%
   \<Monthly             211                        12.3%                                12    4.2%    229    13.3%   26   9.2%
   \>Monthly, \<weekly   172                        10.0%                                60    21.2%   101    5.9%    73   25.8%
   \>Weekly, \<daily     55                         3.2%                                 83    29.3%   24     1.4%    74   26.1%
   \>Daily               47                         2.7%                                 120   42.4%   16     0.9%    97   34.3%
  Heartburn                                                                                                                
   Never                 1159                       67.5%                                9     3.2%    1321   76.9%   13   4.6%
   \<Monthly             243                        14.2%                                9     3.2%    231    13.5%   20   7.1%
   \>Monthly, \<weekly   191                        11.1%                                57    20.1%   110    6.4%    65   23.0%
   \>Weekly, \<daily     86                         5.0%                                 88    31.1%   41     2.4%    89   31.4%
   \>Daily               38                         2.2%                                 120   42.4%   14     0.8%    96   33.9%
  Regurgitation                                                                                                            
   Never                 1349                       78.6%                                23    8.1%    1444   84.1%   27   9.5%
   \<Monthly             186                        10.8%                                20    7.1%    170    9.9%    31   11.0%
   \>Monthly, \<weekly   111                        6.5%                                 62    21.9%   75     4.4%    72   25.4%
   \>Weekly, \<daily     57                         3.3%                                 101   35.7%   24     1.4%    90   31.8%
   \>Daily               14                         0.8%                                 77    27.2%   4      0.2%    63   22.3%
  Nausea                                                                                                                   
   Never                 1291                       75.2%                                21    7.4%    1410   82.1%   23   8.1%
   \<Monthly             246                        14.3%                                22    7.8%    205    11.9%   38   13.4%
   \>Monthly, \<weekly   108                        6.3%                                 74    26.1%   68     4.0%    84   29.7%
   \>Weekly, \<daily     52                         3.0%                                 71    25.1%   27     1.6%    67   23.7%
   \>Daily               20                         1.2%                                 95    33.6%   7      0.4%    71   25.1%

SF-LDQ, Short Form Leeds Dyspepsia Questionnaire.

Effect of dyspepsia on quality of life (SF-NDI) {#s3-5}
-----------------------------------------------

For all the assessed quality of life indicators, dyspepsia was associated with significantly lower GI-QoL when compared with non-dyspeptic controls. The presence of dyspepsia was therefore associated with a negative impact on all of: feelings of tension and anxiety, with interference with daily activities score, disruption to regular eating and drinking habits, knowledge towards control disease, and interference with work (all p\<0.0001, [table 4](#T4){ref-type="table"}).

###### 

SF-NDI comparison (dyspeptics vs non-dyspeptics)

  SF-NDI variables                                Dyspeptics (mean)   Non-dyspeptics (mean)   Difference (means)   95% CI (difference)   P value
  ----------------------------------------------- ------------------- ----------------------- -------------------- --------------------- ----------
  Tension/anxiety score                           10.61               2.75                    7.86                 7.34 to 8.37          \<0.0001
  Interference with daily activities score        10.46               2.56                    7.90                 7.40 to 8.40          \<0.0001
  Disruption with regular eating/drinking score   11.01               2.87                    8.14                 7.62 to 8.66          \<0.0001
  Knowledge/control disease score                 8.4                 2.16                    6.24                 5.83 to 6.65          \<0.0001
  Interference with work score                    10.69               2.57                    8.12                 7.62 to 8.62          \<0.0001
  Overall score                                   47.44               10.18                   37.27                34.97 to 39.56        \<0.0001

SF-NDI, Short Form Nepean Dyspepsia Index.

Univariate analysis of dyspepsia severity (SF-NDI) {#s3-6}
--------------------------------------------------

Risk factors for a worse dyspepsia severity (via the SF-NDI, once dyspepsia was established) that reached significance in a univariate model (see [table 5](#T5){ref-type="table"}) were socioeconomic status only.

###### 

Univariate dyspepsia severity risk factors (SF-NDI)

  Variable               Coefficient   SE       P value   95% CI
  ---------------------- ------------- -------- --------- --------------------
  Age                    −0.06         0.056    0.347     −0.215 to 0.096
  Gender                                                  
   Male                  --            --       --        
   Female                −8.597        4.928    0.156     −22.28 to 5.087
  Profession                                              
   Unemployed            --            --       --        
   Farmer                −3.666        5.151    0.516     −17.966 to 10.635
   Student               −9.095        16.587   0.613     −55.147 to 36.957
   Private sector        −10.538       6.123    0.16      −27.539 to 6.462
   Public sector         −27.354       9.927    0.051     −54.916 to 0.208
  Socioeconomic status                                    
   Category 1            --            --       --        
   Category 2            −6.773        3.119    0.118     −16.699 to 3.153
   Category 3            −9.058        2.428    0.034\*   −16.787 to −1.33
   Category 4            −22.864       2.856    0.004\*   −31.953 to −13.774
  Marital status                                          
   Single                --            --       --        
   Married               −5.668        4.174    0.246     −17.258 to 5.922
   Divorced              −29.815       20.635   0.222     −87.106 to 27.476
   Widow                 −1.815        8.613    0.843     −25.729 to 22.099
  Having children                                         
   Has children          --            --       --        
   No children           8.105         5.661    0.225     −7.612 to 23.823
  Smoking                                                 
   Never                 --            --       --        
   In the past           2.178         3.841    0.601     −8.488 to 12.843
   Currently             6.75          7.993    0.446     −15.441 to 28.941
  NSAID use                                               
   Never                 --            --       --        
   In the past           −2.364        4.744    0.644     −15.536 to 10.808
   Currently             −5.991        8.297    0.51      −29.026 to 17.045
  Aspirin use                                             
   Never                 --            --       --        
   In the past           0.859         1.691    0.638     −3.835 to 5.554
   Currently             −3.996        6.825    0.59      −22.945 to 14.952
  Alcohol use                                             
   Never                 --            --       --        
   In the past           0.219         5.767    0.972     −15.793 to 16.231
   Currently             1.593         5.767    0.796     −14.418 to 17.605

\*Denotes a significant value with p\<0.05.

NSAID, non-steroidal anti-inflammatory drug; SF-NDI, Short Form Nepean Dyspepsia Index.

Multivariate analysis of dyspepsia severity (SF-NDI) {#s3-7}
----------------------------------------------------

Using a multivariate logistic regression model, none of the univariate factors reached significance with regard to dyspepsia severity.

Discussion {#s4}
==========

This study describes a high prevalence of 14.2% of clinically significant dyspepsia among the community-based Rwandan population. It demonstrates a major reduction of GI-QoL among those with dyspepsia, and shows that, as in other populations, gender, socioeconomic status and lifestyle factors are significant modifiers of dyspepsia prevalence in Rwanda.^6\ 11^ This is the first study of which we are aware to describe in depth the epidemiology and burden of dyspepsia in Rwanda. It validates the growing concern for dyspepsia as a major driver of reduced quality of life and increased healthcare utilisation in sub-Saharan Africa, which is still poorly characterised and understood.

This is the first African study to use a rigorous sampling method and definition of dyspepsia applied to the general population instead of those already presenting to healthcare for other potentially related reasons. Other studies from Africa reporting high headline dyspepsia prevalence have either enrolled an endoscopy referral population, used a liberal definition of dyspepsia, or both, leaving the extrapolation of their findings to clinical and public health practice in the wider population open to question. For example, the general population dyspepsia prevalence of 14.1% found in this study is lower than the prevalences of 45%, 26% and 29% found in prior African work conducted in Nigeria.[@R8] Similarly, in a study from Kenya, in adult diabetics attending an outpatient setting, 53.3% suffered from dyspepsia.[@R17] In lower income settings further afield, dyspepsia has been reported at prevalences of 29.9% and 54.6% in Iran,[@R18] 30.4% in India,[@R20] and 60.1% in Jordan.[@R21] Globally, the prevalence of dyspepsia has been estimated at 21%, though with geographical and methodological variation.[@R22]

Many of these studies used different tools to assess dyspepsia, many using a much looser definition of any upper abdominal discomfort and others using older Rome criteria. Although a direct comparison is not possible, if our study was to assume a definition of dyspepsia that included any upper abdominal pain in the last month, the reported headline prevalence would dramatically increase (from 14.1% to 92.9%). A strength to our study is this rigorous, internationally validated, definition. It is unclear whether the international prevalence differences noted above are due to corresponding differences in disease definition, true disease burden or both. Further work at an epidemiological level in other African countries is certainly required.

Bitwayiki *et al*'s previous Rwandan study,[@R6] conducted in a single tertiary hospital survey of healthcare workers and using a liberal definition of dyspepsia, had estimated the prevalence to be 38.9%[@R6] in that population. The definition of dyspepsia used in the current study was much stricter, corresponding to the category of 'severe dyspepsia' in that study, with 10.2% being the corresponding comparator prevalence from that study. The current work thus suggests that clinically significant (or 'severe') dyspepsia is more prevalent among the general population than healthcare workers in Rwanda, possibly due to differences in health literacy, illness behaviour and access to care between healthcare workers and the wider population.

Dyspepsia risk factors {#s4-1}
----------------------

### Gender {#s4-1-1}

We found female gender to be a significant risk factor in both the univariate and multivariate models for the prevalence of dyspepsia, but not dyspepsia's impact on quality of life. The two previous studies in Rwanda suggest a female preponderance among those with dyspepsia,[@R6] which was also found in this study (36.3% for females vs 21.4% for males). This gender-based risk accords with other international studies,[@R6] and a recent global meta-analysis by Ford *et al*[@R22] also found that for uninvestigated dyspepsia, the prevalence was slightly higher in females compared with males (25.3% vs 21.9%, OR 1.24; 95% CI 1.13 to 1.36), but with significant heterogeneity among studies. In Ford's meta-analysis this did not reach significance in the sub-Saharan African context (OR 0.93, 95% CI 0.73 to 1.19), which may be attributable to the paucity of data, as the subgroup meta-analysis only included two studies both from Nigeria. As yet there has not been a convincing mechanism asserted for the gender discrepancy observed.

### Smoking {#s4-1-2}

Smoking has become increasingly socially taboo in the Rwandan context, and although current smoking has been recognised as a risk factor by Ford *et al* in their meta-analysis (OR 1.25; 95% CI 1.12 to 1.40)[@R22] based on 19 pooled studies, we did not find tobacco use to be a predictor of dyspepsia prevalence or severity in Rwanda in this or our prior study.

Tobacco smoking may impair barrier function via reduced prostaglandin synthesis, mucous secretion, and epidermal growth factor secretion, as well as reducing gastric blood flow[@R24] and potentiating the relaxation of the lower oesophageal sphincter.[@R25] Furthermore, nicotine, a key component of tobacco, potentiates mucosal injury by augmenting pepsin and acid secretion, duodenogastric reflux, and production of free radicals.[@R26] Smoking has also been linked with duodenal eosinophilia, which in turn has been linked with functional dyspepsia.[@R27] However, with the prevalence of current smoking in our study being only 7%, the most likely reason for the lack of any significant effect for smoking on dyspepsia is inadequate power, with the observed effect statistically similar to Ford's work, but with wide CIs.

### Aspirin and NSAIDs {#s4-1-3}

We observed current and past aspirin use to be a significant risk factor in univariate analysis and multivariate analysis for the presence of dyspepsia, but not severity. Current NSAID use was a risk factor in univariate but not multivariate analysis for the presence of dyspepsia, but also did not predict severity.

Aspirin and NSAIDs may cause gastroduodenal toxicity via various mechanisms, including prostaglandin and nitric oxide inhibition which may cause increased gastric acid secretion, decreased mucus and bicarbonate secretion, decreased cell proliferation, decreased mucosal blood flow and increased intestinal permeability.[@R28] However, similar to tobacco, the relationship between medication use and dyspepsia is complex, as the presence of dyspepsia may in turn discourage clinicians and patients from using aspirin and NSAIDs.

NSAIDs have been implicated internationally as a risk factor for dyspepsia (OR 1.59; 95% CI 1.27 to 1.99)[@R22] and 'Indulgence in self-medication' was found to be a significant risk factor for unexplained dyspepsia in Nigeria.[@R8] However, generally, there are a paucity of data in this area to further delineate the association, and a longitudinal study of African population-based cohorts may be required to tease out the temporal relationships involved.

### Alcohol {#s4-1-4}

Alcohol use in the past was found to be a significant risk factor in both the univariate and multivariate models, but did not predict severity. Current use of alcohol was not predictive of dyspepsia presence or severity.

Alcohol decreases gastric motility in mice[@R29] and human subjects[@R30] as well as increasing intestinal permeability and microbiotal alterations.[@R31] The association of alcohol with dyspepsia has been inconsistent, and it has previously not been demonstrated to be significant in the Rwandan[@R6] and wider sub-Saharan African[@R32] context. While other explanations are possible, including the lack of any true effect of alcohol on dyspepsia, this may be due to cultural or clinical beliefs encouraging those with dyspepsia to reduce or cease their alcohol intake. Once again, a cohort study would be required to better delineate the nature of this potentially complex relationship over time.

### Socioeconomic status and profession {#s4-1-5}

Socioeconomic status did not predict the presence, but did predict the severity of dyspepsia in a univariate but not multivariate model (with greater affluence being protective).

The link with dyspepsia and socioeconomic status has not been consistently identified, with many negative studies.[@R33] However, there may be a socioeconomic link with *Helicobacter pylori* infection,[@R12] and which was also found in Denmark by Wildner-Christensen *et al*[@R37] and the UK,[@R38] and unemployment was implicated in a study across seven international sites.[@R39] In the Rwandan context, higher educational attainment has previously been found to be protective,[@R6] suggesting that there may be true variation depending on the prevalence of *H. pylori* in the population.

One issue with evaluating an association in general is the different socioeconomic status strata, cultures, average incomes, professions and sanitary conditions in these groups internationally. This means that international comparisons of lower socioeconomic groups involve significant heterogeneity and are generally problematic.

Impact on quality of life {#s4-2}
-------------------------

In our study, the most frequent and most troublesome symptoms for dyspeptic participants were abdominal pain and heartburn, followed by nausea. This result is similar to those previously found in Rwanda,[@R6] the UK,[@R12] and Malaysia.[@R7]

Participants with dyspepsia had significant reduced GI-QoL, with SF-NDI mean subscores ranging from 8.4 to 11.0, compared with 2.2 to 2.9 in non-dyspeptics (p\<0.0001 for each). This severe impact on participants' quality of life further validates the clinical relevance of the strict definition of dyspepsia used. It also shows the importance that should be placed on dyspepsia at a population level, as untreated dyspepsia debilitates people, and some pathologies underlying dyspepsia can cause major morbidity or death.

Strengths and limitations {#s4-3}
-------------------------

This is the first study we are aware of characterising the prevalence and burden of dyspepsia in the Rwandan general population.

Some specific strengths of this study are the large population data set and the stratified sampling technique used. Whereas previous studies have characterised certain subpopulations or locations, we endeavoured to accurately recruit a representative population across the whole country in a systematic matter. A further strength is the validated and internationally comparable questionnaire used in data collection, and the native Rwandan and Kinyarwanda speakers used to approach the participants.

We used a much stricter definition of dyspepsia than most other studies, a definition which is robust and well validated in this context. Though compared with more liberal definitions of dyspepsia, our approach underestimates the headline dyspepsia prevalence figure, the major impact on observed quality of life demonstrates the merit of our approach identifying those with significant afflictions, who could be the target for further research on endoscopy findings and targeted interventions. On the other hand, we could not assess early satiety or postprandial fullness as these are not included on the SF-LDQ and it is possible we underestimated the prevalence of dyspepsia.

We recruited a female preponderance, and predominantly participants from a low socioeconomic background. However, given the general population of Rwanda and the 1994 genocide that predominantly affected males,[@R40] this likely describes the Rwandan population and therefore validates our sampling technique. Due to the sampling technique, we were unable to recruit participants from small villages (under 100 people), and though we are not aware of any evidence this would affect the data collection, we cannot know and therefore rule out that this would introduce a small bias. Because participants were recruited from their own homes and clustered sampling in villages was done, there is a possibility of systematic bias in that those available at home may differ from those not available.

As a cross-sectional survey, the study could not inform us about causality, nor specifically whether the symptoms had attributable organic pathology or were from functional dyspepsia---and whether uninvestigated dyspepsia has a different natural history in this population to others. We were also unable to assess changes in the participants' dyspepsia and quality of life scores over time, as is usual with single time point cross-sectional surveys. Further follow-up and investigation in the studied cohort may be informative in this regard.

Conclusion {#s5}
==========

This study describes a high dyspepsia prevalence, and major associated quality of life burden, in the general Rwandan population. These data add weight to the increasing importance that is being placed on dyspepsia in the sub-Saharan and global context, and emphasise the need for further efforts directed towards investigating the causes of this symptom burden, as well as effective public health and clinical strategies to reducing dyspepsia prevalence and burden in Africa. We believe further research efforts should be directed towards eliciting the aetiology and associated factors directing both dyspepsia prevalence and severity, and particularly whether such factors are global in nature or unique to the Rwandan or sub-Saharan African setting.
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